Alteration of cardiac ACE2/Mas expression and cardiac remodelling in rats with aortic constriction

Chinese Journal of Physiology

Volumn 57, Issue 6, 2014, Pages 335-342

  Zhang, Yanling ^a   Li, Bing ^a   Wang, Bingxiang ^a   Zhang, Jingjun ^a   Wu, Junyan ^a   Morgan, Trefor ^b  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

ACE2; Aortic constriction; Fibrosis; Hypertension; Hypertrophy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; LOSARTAN; MAS RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; ONCOPROTEIN; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; HEART WEIGHT; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; PROTEIN EXPRESSION; RAT; ABDOMINAL AORTA; ANIMAL; CARDIOMEGALY; GENETICS; HEART MUSCLE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASOCONSTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA, ABDOMINAL; CARDIOMEGALY; LOSARTAN; MALE; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; VASOCONSTRICTION; VENTRICULAR REMODELING;

EID: 84922259071     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2014.BAD268     Document Type: Article

References (35)

1. Amann, K., Rychlík, I., Miltenberger-Milteny, G. and Ritz, E. Left ventricular hypertrophy in renal failure. Kidney Int. 54 (suppl. 68): S78-S85, 1998.
2. Aulakh, G. K., Sodhi, R. K. and Singh, M. An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Life Sci. 81: 615-639, 2007.
3. Boshra, V., El Wakeel, G. A. and Nader, M. A. Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension. Can. J. Physiol. Pharmacol. 89: 103-107, 2011.
4. Burrell, L. M., Risvanis, J., Kubota, E., Dean, R. G., MacDonald, P. S., Lu, S., Tikellis, C., Grant, S. L., Lew, R. A., Smith, A. I., Cooper, M. E. and Johnston, C. I. Myocardial infarction increases ACE2 expression in rat and humans. Eur. Heart J. 26: 369-375, 2005.
5. Chen, H. I. Hemodynamic mechanism of ventricular hypertrophy in hypertension. Chinese J. Physiol. 55: 369-379, 2012.
6. Choudhary, R., Palm-Leis, A., Scott, R. C. 3rd, Guleria, R. S., Rachut, E., Baker, K. M. and Pan, J. All-trans retinoic acid prevents development of cardiac remodeling in aortic banded rats by inhibiting the renin-angiotensin system. Am. J. Physiol. Heart Circ. Physiol. 294: 633-644, 2008.
7. Chuang, T. Y., Chang, F. Y., Juan, C. C. and Wang, P. S. Adaptive roles of adiponectin and resistin in cardiovascular diseases. Adapt. Med. 5: 21-28, 2013.
8. Danilczyk, U. and Penninger, J. M. Angiotensin-converting enzyme II in the heart and the kidney. Circ. Res. 98: 463-471, 2006.
9. Dean, R. G., Balding, L. C., Candido, R., Burns, W. C., Cao, Z., Twigg, S. M. and Burrell, L. M. Connective tissue growth factor and cardiac fibrosis after myocardial infarction. J. Histochem. Cytochem. 53: 1245-1256, 2005.
10. Díez-Freire, C., Vázquez, J., Correa de Adjounian, M. F., Ferrari, M. F., Yuan, L., Silver, X., Torres, R., and Raizada, M. K. ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiol. Genomics. 27: 12-19, 2006.
11. Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., Breitbart, R. E. and Acton, S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin e1-e9. Circ. Res. 87: 1-9, 2000.
12. Donoghue, M., Wakimoto, H., Maguire, C. T., Acton, S., Hales, P., Stagliano, N., Fairchild-Huntress, V., Xu, J., Lorenz, J. N., Kadambi, V., Berul, C. I. and Breitbart, R. E. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J. Mol. Cell Cardiol. 35: 1043-1053, 2003.
13. Ehlers, M. R. and Riordan, J. F. Angiotensin-converting enzyme: zinc-and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 30: 7118-7126, 1991.
14. Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I. and Gallagher, P. E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 111: 2605-2610, 2005.
15. Gamboa, J. L., Pretorius, M., Todd-Tzanetos, D. R., Luther, J. M., Yu, C., Ikizler, T. A. and Brown, N. J. Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blocker on inflammation during hemodialysis. J. Am. Soc. Nephrol. 23: 334-342, 2012.
16. Gavras, H. and Brunner, H. R. Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure. Hypertension 37: 342-345, 2001.
17. Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T. A., Donoghue, M., Breitbart, R. E., Acton, S. L., Rockman, H. A. and Coffman, T. M. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Invest. 116: 2218-2225, 2006.
18. Ishiyama, Y., Gallagher, P. E., Averill, D. B., Tallant, E. A., Brosnihan, K. B. and Ferrario, C. M. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43: 970-976, 2004.
19. Kaiqiang, J., Minakawa, M., Fukui, K., Suzuki, Y. and Fukuda, I. Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs. Hypertension 58: 1093-1098, 2011.
20. Kar, S., Gao, L. and Zucker, I. H. Exercise training normalizes ACE and ACE2 in the brain of rabbits with pacing-induced heart failure. J. Appl. Physiol. 108: 923-932, 2010.
21. Kennedy, D., Omran, E., Periyasamy, S. M., Nadoor, J., Priyadarshi, A., Willey, J. C., Malhotra, D., Xie, Z. and Shapiro, J. I. Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat. J. Am. Soc. Nephrol. 14: 90-97, 2003.
22. Masson, R., Nicklin, S. A., Craig, M. A., McBride, M., Gilday, K., Gregorevic, P., Allen, J. M., Chamberlain, J. S., Smith, G., Graham, D., Dominiczak, A. F., Napoli, C. and Baker, A. H. Onset of experimental severe cardiac fibrosis is mediated by overexpression of Angiotensin-converting enzyme 2. Hypertension 53: 694-700, 2009.
23. Ocaranza, M. P., Godoy, I., Jalil, J. E., Varas, M., Collantes, P., Pinto, M., Roman, M., Ramirez, C., Copaja, M., Diaz-Araya, G., Castro, P. and Lavandero, S. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48: 572-578, 2006.
24. Soro-Paavonen, A., Gordin, D., Forsblom, C., Rosengard-Barlund, M., Waden, J., Thorn, L., Sandholm, N., Thomas, M. C. and Groop, P. H. FinnDiane Study Group. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 30: 375-383, 2012.
25. Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G. and Corvol, P. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc. Natl. Acad. Sci. USA 85: 9386-9390, 1988.
26. Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G. and Turner, A. J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275: 33238-33243, 2000.
27. Titan, S. M., Vieira, J. Jr., Dominguez, W. V., Barros, R. T. and Zatz, R. ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial. Clin. Nephrol. 76: 273-283, 2011.
28. Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., Backx, P. H., Penninger, J. M., Herzenberg, A. M. and Scholey, J. W. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 171: 438-451, 2007.
29. Yamaleyeva, L. M., Gilliam-Davis, S., Almeida, I., Brosnihan, K. B., Lindsey, S. H. and Chappell, M. C. Differential Regulation of Circulating and Renal ACE2 and ACE in hypertensive mRen2. Lewis Rats with Early Onset Diabetes. Am. J. Physiol. Renal Physiol. 302: 1374-1384, 2012.
30. Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., Rakugi, H. and Ogihara, T. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 47: 718-726, 2006.
31. Zemancikova, A. and Torok, J. Diminished contractile responses of isolated conduit arteries in two rat models of hypertension. Chinese J. Physiol. 56: 230-235, 2013.
32. Zhang, Y. and Morgan, T. Effects of aortic ligation on the renin angiotensin system in hydronephrotic mice. Blood Press. 8: 122-127, 1999.
33. Zhang, Y., Wu, J., Zhang, Z., Wang, B., Chen, P. and Jing, X. Effect of low sodium intake and beta-blocker on renin synthesis and secretion in mice with unilateral ureteral ligation. Hypertens. Res. 33: 1258-1263, 2010.
34. Zhang, Z., Sun, X., Wang, B., Zhang, Y., Sun, X. and Chi, X. Study on the expression of ACE and ACE2 in kidney of hypertensive rat model caused by surgery. Chinese J. Clinicians (Elec Edit, in Chinese) 5: 4673-4679, 2011.
35. Zhao, S. M., Li, H. W., Guo, C. Y., and Shen, L. H. Cardiac fibrosis in diabetic rats: regulation and mechanism of activation of the PPARgamma signal pathway. Chinese J. Physiol. 53: 262-267, 2010.